Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530
Last updated 2018-07-16
Summary
RATIONALE: Assessing the long-term effects of cancer treatment in cancer survivors may help improve the ability to plan effective treatment and follow-up care.
PURPOSE: This clinical trial is studying the long-term effects of treatment in patients who were previously treated for childhood Hodgkin's lymphoma.
Conditions
- Long-term Effects Secondary to Cancer Therapy in Children
- Lymphoma
Interventions
- OTHER
-
medical chart review
- OTHER
-
questionnaire administration
- PROCEDURE
-
management of therapy complications
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Debra L. Friedman, MD, MS · Vanderbilt-Ingram Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
- Primary Completion
- 2011-06-27
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003423 ·Status: UNKNOWN ·Phase: PHASE3
-
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
NCT00592111 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
NCT00025064 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
NCT00002691 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
NCT00107198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004010 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
NCT00433459 ·Status: COMPLETED ·Phase: PHASE3
-
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
NCT05518383 ·Status: RECRUITING ·Phase: PHASE4
-
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
NCT00006342 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003650 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
NCT00005578 ·Status: COMPLETED ·Phase: PHASE3
-
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
NCT00002757 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
NCT00187161 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
NCT07291102 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
NCT00398554 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00003217 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002618 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
NCT02797717 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
NCT00416377 ·Status: UNKNOWN ·Phase: NA
-
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
NCT03213665 ·Status: COMPLETED ·Phase: PHASE2
-
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
NCT00005952 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
NCT00666484 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
NCT00070304 ·Status: COMPLETED ·Phase: PHASE2